| Abstrakt: |
A recent study conducted by researchers at AlMaarefa University in Riyadh, Saudi Arabia, explored the potential benefits of transcutaneous vagus nerve stimulation (tVNS) in treating non-alcoholic fatty liver disease (NAFLD) in rats. The study found that tVNS significantly improved various markers of liver health, including liver function, serum lipid profile, and oxidative stress and inflammatory indicators. The researchers concluded that tVNS may be a promising therapeutic option for managing NAFLD induced by obesity and could help protect the liver from obesity-related damage. This research provides valuable insights into potential treatments for NAFLD and its associated health risks. [Extracted from the article] |
